Tim Smith

Senior Lecturer

Bangor University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tim Smith is a Senior Lecturer at Bangor University, located in the United Kingdom. His research primarily focuses on gene expression, hypoxia in cancer, and the application of innovative therapeutic approaches for bladder and prostate cancer. Recent articles authored by him explore topics such as the immune effects of radionuclides, cell surface proteomics, and the potential of CRISPR–Cas9 technology in identifying therapeutic targets.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Collaborators (5)

Richard Unwin

The University of Manchester

UNITED KINGDOM

View details

Peter Hoskin

The University of Manchester

UNITED KINGDOM

View details

Hitesh Mistry

The University of Manchester

UNITED KINGDOM

View details

Michael Rushton

Senior Lecturer

Bangor University

UNITED KINGDOM

View details

Catharine West

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tim Smith

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to Hypoxia

Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer

Apparatus and Experiments Towards Fully Automated Medical Isotope Production Using an Ion Beam Accelerator

CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

Modelling Potential Candidates for Targeted Auger Therapy

Immune effects of α and β radionuclides in metastatic prostate cancer

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts

Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Collaborators (5)

Richard Unwin

Peter Hoskin

Hitesh Mistry

Michael Rushton

Catharine West

Make your next move.